Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Every US company we alert on

5,765 US-listed companies, ranked by market cap. Open any company to see every SEC filing alert we sent for it: 8-K material events, deals, capital raises, results, leadership changes and insider trades.

#CompanySectorMarket capAlertsLatest
1385 Prestige Consumer Healthcare Inc.NYSE: PBH Life Sciences $2.28B 2 Financial ResultsNov 5, 2026
1391 Perrigo Co plcNYSE: PRGO Life Sciences $2.25B 2 Financial ResultsNov 4, 2026
1392 Celldex Therapeutics, Inc.NASDAQ: CLDX Life Sciences $2.25B 3 Financial ResultsNov 5, 2026
1406 Beam Therapeutics Inc.NASDAQ: BEAM Life Sciences $2.17B 3 Financial ResultsNov 3, 2026
1415 Palvella Therapeutics, Inc.NASDAQ: PVLA Life Sciences $2.11B 7 Insider SellingNov 12, 2026
1420 Biohaven Ltd.NYSE: BHVN Life Sciences $2.08B 5 Investor PresentationNov 16, 2026
1422 Immunome Inc.NASDAQ: IMNM Life Sciences $2.08B 3 Financial ResultsNov 9, 2026
1424 Aurinia Pharmaceuticals Inc.NASDAQ: AUPH Life Sciences $2.07B 2 Financial ResultsOct 30, 2026
1438 Replimune Group, Inc.NASDAQ: REPL Life Sciences $2.03B 5 Insider SellingNov 10, 2026
1452 Septerna, Inc.NASDAQ: SEPN Life Sciences $1.98B 6 Insider SellingNov 16, 2026
1456 First Tracks Biotherapeutics, Inc.NASDAQ: TRAX Life Sciences $1.96B 5 Financial ResultsNov 3, 2026
1459 Vera Therapeutics, Inc.NASDAQ: VERA Life Sciences $1.95B 3 Financial ResultsNov 5, 2026
1462 Harmony Biosciences Holdings, Inc.NASDAQ: HRMY Life Sciences $1.94B 5 Financial ResultsNov 4, 2026
1468 Biocryst Pharmaceuticals IncNASDAQ: BCRX Life Sciences $1.92B 2 Financial ResultsNov 4, 2026
1471 Trevi Therapeutics, Inc.NASDAQ: TRVI Life Sciences $1.89B 2 Financial ResultsNov 9, 2026
1472 Zenas BioPharma, Inc.NASDAQ: ZBIO Life Sciences $1.89B 4 Capital RaiseNov 6, 2026
1483 Maze Therapeutics, Inc.NASDAQ: MAZE Life Sciences $1.85B 8 Financial ResultsNov 9, 2026
1486 Eton Pharmaceuticals, Inc.NASDAQ: ETON Life Sciences $1.84B 10 Insider SellingNov 12, 2026
1493 Zymeworks Inc.NASDAQ: ZYME Life Sciences $1.83B 7 Insider SellingNov 16, 2026
1494 Hemab Therapeutics Holdings, Inc.NASDAQ: COAG Life Sciences $1.83B 3 Financial ResultsNov 10, 2026
1499 Recursion Pharmaceuticals, Inc.NASDAQ: RXRX Life Sciences $1.81B 7 Insider SellingNov 4, 2026
1501 Agios Pharmaceuticals, Inc.NASDAQ: AGIO Life Sciences $1.8B 4 Financial ResultsNov 5, 2026
1517 Braveheart Bio, Inc.NASDAQ: BRVE Life Sciences $1.75B 3 Financial ResultsNov 10, 2026
1520 Stoke Therapeutics, Inc.NASDAQ: STOK Life Sciences $1.74B 6 Insider SellingNov 4, 2026
1541 Supernus Pharmaceuticals, Inc.NASDAQ: SUPN Life Sciences $1.68B 7 M&A DealNov 2, 2026
1556 Vir Biotechnology, Inc.NASDAQ: VIR Life Sciences $1.64B 9 Capital RaiseNov 16, 2026
1561 Kailera Therapeutics, Inc.NASDAQ: KLRA Life Sciences $1.63B 2 Financial ResultsNov 4, 2026
1567 Sarepta Therapeutics, Inc.NASDAQ: SRPT Life Sciences $1.62B 3 Financial ResultsNov 5, 2026
1569 Ultragenyx Pharmaceutical Inc.NASDAQ: RARE Life Sciences $1.62B 7 Financial ResultsNov 4, 2026
1576 Nurix Therapeutics, Inc.NASDAQ: NRIX Life Sciences $1.61B 11 Insider SellingNov 4, 2026
1586 ADARx Pharmaceuticals, Inc.NASDAQ: ADRX Life Sciences $1.56B 8 Financial ResultsNov 12, 2026
1593 Precigen, Inc.NASDAQ: PGEN Life Sciences $1.54B 2 Financial ResultsNov 5, 2026
1595 uniQure N.V.NASDAQ: QURE Life Sciences $1.53B 6 Insider SellingNov 10, 2026
1601 Sellas Life Sciences Group, Inc.NASDAQ: SLS Life Sciences $1.52B 3 Clinical Trial DataNov 17, 2026
1611 Immunocore Holdings plcNASDAQ: IMCR Life Sciences $1.49B 3 Financial ResultsNov 6, 2026
1614 Korsana Biosciences, Inc.NASDAQ: KRSA Life Sciences $1.49B 2 Financial ResultsNov 5, 2026
1619 Rapport Therapeutics, Inc.NASDAQ: RAPP Life Sciences $1.47B 15 Financial ResultsNov 4, 2026
1624 Pacira BioSciences, Inc.NASDAQ: PCRX Life Sciences $1.46B 6 M&A DealNov 17, 2026
1647 Damora Therapeutics, Inc.NASDAQ: DMRA Life Sciences $1.39B 2 Financial ResultsNov 4, 2026
1648 Lb Pharmaceuticals IncNASDAQ: LBRX Life Sciences $1.39B 3 Financial ResultsNov 5, 2026
1649 Intellia Therapeutics, Inc.NASDAQ: NTLA Life Sciences $1.38B 6 Investor PresentationNov 13, 2026
1650 UroGen Pharma Ltd.NASDAQ: URGN Life Sciences $1.38B 3 Financial ResultsNov 4, 2026
1655 Anaptysbio, IncNASDAQ: ANAB Life Sciences $1.37B 4 Financial ResultsNov 12, 2026
1656 Tyra Biosciences, Inc.NASDAQ: TYRA Life Sciences $1.36B 3 Financial ResultsNov 10, 2026
1661 Nuvation Bio Inc.NYSE: NUVB Life Sciences $1.36B 3 Earnings CallNov 4, 2026
1663 Generate Biomedicines, Inc.NASDAQ: GENB Life Sciences $1.35B 3 Financial ResultsNov 12, 2026
1670 Novavax IncNASDAQ: NVAX Life Sciences $1.33B 3 Financial ResultsNov 5, 2026
1673 Taysha Gene Therapies, Inc.NASDAQ: TSHA Life Sciences $1.32B 2 Financial ResultsNov 12, 2026
1676 Ocular Therapeutix, IncNASDAQ: OCUL Life Sciences $1.32B 8 Insider SellingNov 9, 2026
1678 Avalyn Pharma Inc.NASDAQ: AVLN Life Sciences $1.32B 4 Insider SellingNov 12, 2026
1680 Innoviva, Inc.NASDAQ: INVA Life Sciences $1.31B 2 Financial ResultsNov 4, 2026
1692 Mineralys Therapeutics, Inc.NASDAQ: MLYS Life Sciences $1.29B 6 Financial ResultsNov 4, 2026
1695 Mannkind CorpNASDAQ: MNKD Life Sciences $1.27B 2 Financial ResultsNov 5, 2026
1703 Nektar TherapeuticsNASDAQ: NKTR Life Sciences $1.25B 5 Investor MeetingNov 13, 2026
1707 Amphastar Pharmaceuticals, Inc.NASDAQ: AMPH Life Sciences $1.24B 2 Financial ResultsNov 5, 2026
1709 Omeros CorpNASDAQ: OMER Life Sciences $1.24B 4 Earnings CallNov 16, 2026
1726 Opko Health, Inc.NASDAQ: OPK Life Sciences $1.2B 5 Insider SellingNov 5, 2026
1727 Kardigan, Inc.NASDAQ: KARD Life Sciences $1.2B 4 Financial ResultsNov 12, 2026
1729 Cronos Group Inc.NASDAQ: CRON Life Sciences $1.2B 3 Financial ResultsNov 5, 2026
1739 Compass Pathways plcNASDAQ: CMPS Life Sciences $1.17B 2 Financial ResultsNov 3, 2026
1741 Vor Biopharma Inc.NASDAQ: VOR Life Sciences $1.17B 2 Licensing DealNov 12, 2026
1748 Inhibrx Biosciences, Inc.NASDAQ: INBX Life Sciences $1.15B 4 Financial ResultsNov 13, 2026
1775 Harrow, Inc.NASDAQ: HROW Life Sciences $1.09B 4 Investor PresentationNov 16, 2026
1777 Alto Neuroscience, Inc.NYSE: ANRO Life Sciences $1.09B 3 Financial ResultsNov 10, 2026
1790 Jade Biosciences, Inc.NASDAQ: JBIO Life Sciences $1.06B 4 Earnings CallNov 13, 2026
1812 Seaport Therapeutics, Inc.NASDAQ: SPTX Life Sciences $1.02B 3 Insider BuyingNov 4, 2026
1825 Cryoport, Inc.NASDAQ: CYRX Life Sciences $1B 4 Insider SellingNov 12, 2026
1829 MoonLake ImmunotherapeuticsNASDAQ: MLTX Life Sciences $998M 2 Financial ResultsNov 4, 2026
1833 Savara IncNASDAQ: SVRA Life Sciences $985M 1 Financial ResultsNov 9, 2026
1841 Verastem, Inc.NASDAQ: VSTM Life Sciences $970M 7 Insider SellingNov 5, 2026
1866 Odyssey Therapeutics, Inc.NASDAQ: ODTX Life Sciences $931M 3 Financial ResultsNov 4, 2026
1882 Corvus Pharmaceuticals, Inc.NASDAQ: CRVS Life Sciences $894M 3 Insider BuyingNov 13, 2026
1903 MeiraGTx Holdings plcNASDAQ: MGTX Life Sciences $854M 5 Financial ResultsNov 12, 2026
1912 Latigo Biotherapeutics, Inc.NASDAQ: LTGO Life Sciences $835M 2 Financial ResultsNov 5, 2026
1920 Rigel Pharmaceuticals IncNASDAQ: RIGL Life Sciences $823M 1 Financial ResultsNov 5, 2026
1924 Syndax Pharmaceuticals IncNASDAQ: SNDX Life Sciences $815M 3 Financial ResultsNov 2, 2026
1938 Ironwood Pharmaceuticals IncNASDAQ: IRWD Life Sciences $803M 3 Financial ResultsNov 5, 2026
1943 Collegium Pharmaceutical, IncNASDAQ: COLL Life Sciences $790M 3 Financial ResultsNov 5, 2026
1947 Monte Rosa Therapeutics, Inc.NASDAQ: GLUE Life Sciences $783M 3 Financial ResultsNov 5, 2026
1948 Oric Pharmaceuticals, Inc.NASDAQ: ORIC Life Sciences $782M 5 Financial ResultsNov 16, 2026
1952 Lexicon Pharmaceuticals, Inc.NASDAQ: LXRX Life Sciences $779M 3 Insider BuyingNov 9, 2026
1956 Ardelyx, Inc.NASDAQ: ARDX Life Sciences $772M 2 Financial ResultsNov 3, 2026
1959 Obsidian Therapeutics, Inc.NASDAQ: OBX Life Sciences $764M 2 Financial ResultsNov 12, 2026
1964 Prime Medicine, Inc.NASDAQ: PRME Life Sciences $762M 4 Financial ResultsNov 12, 2026
1974 Aura Biosciences, Inc.NASDAQ: AURA Life Sciences $751M 2 Financial ResultsNov 9, 2026
1988 Solid Biosciences Inc.NASDAQ: SLDB Life Sciences $723M 2 Financial ResultsNov 4, 2026
2006 QuidelOrtho CorpNASDAQ: QDEL Life Sciences $701M 4 Financial ResultsNov 4, 2026
2024 Apnimed, Inc.NASDAQ: APMD Life Sciences $678M 3 Financial ResultsNov 16, 2026
2029 Attovia Therapeutics, Inc.NASDAQ: ATTO Life Sciences $672M 2 Financial ResultsNov 9, 2026
2032 Janux Therapeutics, Inc.NASDAQ: JANX Life Sciences $668M 2 Financial ResultsNov 5, 2026
2035 Achieve Life Sciences, Inc.NASDAQ: QUIT Life Sciences $667M 3 Financial ResultsNov 10, 2026
2040 Nuvectis Pharma, Inc.NASDAQ: NVCT Life Sciences $657M 2 Financial ResultsNov 4, 2026
2047 Kura Oncology, Inc.NASDAQ: KURA Life Sciences $651M 3 Insider BuyingNov 16, 2026
2050 Bicara Therapeutics Inc.NASDAQ: BCAX Life Sciences $647M 2 Financial ResultsNov 9, 2026
2052 Olema Pharmaceuticals, Inc.NASDAQ: OLMA Life Sciences $645M 4 Other 8-K FilingNov 12, 2026
2062 Design Therapeutics, Inc.NASDAQ: DSGN Life Sciences $635M 2 Financial ResultsNov 4, 2026
2067 Immix Biopharma, Inc.NASDAQ: IMMX Life Sciences $627M 4 Business UpdateNov 12, 2026
2071 Arbutus Biopharma CorpNASDAQ: ABUS Life Sciences $619M 4 Investor PresentationNov 12, 2026
2072 Cullinan Therapeutics, Inc.NASDAQ: CGEM Life Sciences $617M 8 Financial ResultsNov 10, 2026
2073 Surrozen, Inc.NASDAQ: SRZN Life Sciences $616M 7 Capital RaiseNov 16, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.